innovation for industry
Article | Micro-nanoelectronics
A unique interface between patients and the medical industry
Hub4aim has an unique proposal to manage the preindustrial
phase from the proof of concept to regulatory marking.
Iprasense has just released its third product, one that leverages a lensless imaging technology protected by around a dozen patents. The company’s latest offering is particularly well-suited for high-throughput cellular screening in drug discovery.
The Epicool project is investigating the use of optics to cool epileptogenic areas in the brains of epilepsy patients resistant to other treatments. A prototype implantable device is currently being developed and will be miniaturized before animal testing begins.
Leti, a CEA Tech institute, has developed non-cooled spectrometric detector that can clearly distinguish breast tumor tissue from healthy tissue in mice at a glance.
EU Horizon 2020 project REDFINCH is tackling the next generation of miniaturized portable optical sensors to detect gases and proteins in liquid. The sensors under development will initially target the petrochemical and dairy industries.
In November 2013, IPRASENSE and Leti started an exclusive research cooperation for developing cell culture monitoring techniques based on Leti-patented Lensfree imaging technology.
Nano-biotechnology PlatformClinatec Platform
Connected Health ＆ WellnessAgriculture, Food Industry ＆ Environment
Smart Medical Technologies
See all demos
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.